Role of the local bone renin‑angiotensin system in steroid‑induced osteonecrosis in rabbits

Yongtao Zhang1, Kunzheng Wang1, Qichun Song1

  • 1Department of Orthopaedics, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China.

Molecular Medicine Reports
|February 26, 2014
PubMed

Insights

Steroid-induced osteonecrosis (ON) is linked to the activation of the local bone renin-angiotensin system (RAS). Changes in RAS components precede ON development in rabbits, suggesting a potential therapeutic target.

Area of Science:

  • Biomedical Research
  • Bone Biology
  • Pharmacology

Background:

  • The pathogenesis of steroid-induced osteonecrosis (ON) remains unclear, with limited prophylactic therapies.
  • The local renin-angiotensin system (RAS) plays a role in bone regulation.
  • The connection between bone RAS and steroid-induced ON has not been previously investigated.

Purpose of the Study:

  • To investigate the interrelation between the local bone renin-angiotensin system (RAS) and steroid-induced osteonecrosis (ON).
  • To examine the expression of RAS components in the bone following methylprednisolone acetate (MPA) administration.

Main Methods:

  • 45 rabbits received a single intramuscular dose of methylprednisolone acetate (MPA).
  • Rabbits were sacrificed at 1, 2, and 3 weeks post-injection (n=15 per group).
  • Histopathological examination of femoral heads and detection of mRNA and protein expression of Angiotensin II (Ang II), Angiotensin Converting Enzyme (ACE), and AT1/AT2 receptors in bone.

Main Results:

  • Significant alterations in Ang II, ACE, AT1, and AT2 receptor expression were observed in rabbit bone.
  • Ang II and ACE expression peaked at 1 week post-MPA, while AT1 and AT2 receptor expression peaked at 2 weeks.
  • Osteonecrosis (ON) was most pronounced at 3 weeks, with observed RAS changes preceding ON onset.

Conclusions:

  • The local bone renin-angiotensin system (RAS) is activated following methylprednisolone acetate (MPA) administration.
  • Changes in bone RAS components precede the development of steroid-induced osteonecrosis (ON) in this rabbit model.
  • Activation of the local bone RAS is strongly associated with steroid-induced ON, indicating its potential role in pathogenesis.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.9K